Meet The Leukemia & Lymphoma Society's Executive Leadership Team


Louis J. DeGennaro, Ph.D.

Louis J. DeGennaro, Ph.D.

President and Chief Executive Officer

Louis J. DeGennaro, Ph.D., was named president and chief executive officer of the The Leukemia & Lymphoma Society (LLS) in September 2014. LLS is the world's largest voluntary health agency dedicated to blood cancer. The LLS mission is to cure leukemia, lymphoma, Hodgkin's disease and myeloma, and improve the quality of life of patients and their families.

DeGennaro leads the operations of this $300 million cancer patient advocacy agency with headquarters in Rye Brook, New York.

DeGennaro has been a critical member of the LLS executive leadership team since he joined LLS in 2005. He is recognized as the key architect of LLS's cures and access agenda to help save the lives of blood cancer patients and the LLS Therapy Acceleration Program® -- a venture philanthropy endeavor that defined the role of nonprofit organizations in supporting drug discovery and development with the biotechnology industry. He was named LLS chief mission officer in 2009, with responsibility for leadership of LLS's mission functions of research, patient access, education, public policy and advocacy.

DeGennaro has more than 25 years of research, drug development and executive management experience in academic and private sector settings. He received his doctorate in biochemistry from the University of California at San Francisco and did his post-doctoral research at the Yale University School of Medicine.  His previous academic appointments include research group leader, Max Planck Institute in Munich, Germany, where his laboratory was among the first to clone genes expressed exclusively in the nervous system; and associate professor of neurology and cell biology, University of Massachusetts Medical School.

DeGennaro's private-sector positions include senior director of molecular genetics at Wyeth Pharmaceuticals, Princeton, N.J., where his department contributed to the development of pantoprazole (Protonix®) to treat acid reflux disease, venlafaxine (Effexor®) for anxiety and depression, and gentuzumab ozogamicin (Mylotarg®) for leukemia; executive vice president for research and development, SynX Pharma, Inc., in Toronto, Canada, where he was responsible for the development of a point-of-care diagnostic test for congestive heart failure; and research manager at Streck, Inc., Omaha, Neb., where he helped develop an FDA-cleared diagnostic test for AIDS/HIV.

DeGennaro was appointed by the U.S. Secretary of Health and Human Services in 2012 to serve as a member of the National Center for Advancing Translational Sciences Advisory Council, and the Cures Acceleration Network Review Board at the National Institutes of Health (NIH). He also serves on the boards of BioTheryX, Inc., an early-stage biotechnology company, and the Health Research Alliance, an alliance of non-profit funders of research.

Andrew Coccari

Andrew Coccari

Chief Product Officer

As executive vice president/chief product officer, Andrew Coccari is responsible for leading all campaign and marketing activities and implementing an overall product strategy aligned with LLS’s strategic business plan.  He works closely with management and staff to increase involvement in the various fundraising campaigns that support the LLS mission, including Team In Training (the largest endurance sports training platform), Light The Night, Student Series and Man & Woman of the Year.

Coccari came to LLS with more than 20 years of leadership experience in marketing, sales and product development for well-known brands such as Cannondale, L’Oreal, Honeywell and Shell.  He has built a reputation as an innovator who knows how to establish a clear vision and develop a strategy for successful growth and brand awareness.

He has a M.B.A. in marketing from New York University and a B.S. in environmental science from the State University of New York College of Environmental Sciences and Forestry.


Danielle Gee

Danielle Gee

Chief of Staff

As chief of staff, Danielle Gee is the program manager of the executive team responsible for guiding operational planning, strategic planning, priority initiatives and various enterprise projects. While she provides critical support to LLS President and CEO Louis J. DeGennaro, Ph.D., she also works closely with the cross-functional senior leadership team, primarily to assess progress on LLS’s operating plan. As part of this periodic evaluation, Gee has helped to develop key metrics and analytics, as well as a staff and Board of Directors dashboard and communication plan.

Prior to joining LLS, Gee was associate director of equities sales with UBS Investment Bank in New York City, where she managed relationships with current and prospective clients and provided analysis and research on stock valuations to drive incremental revenue. She previously was a consultant in public financial management, providing strategic consulting services and debt transaction analytical support for municipal clients.

Gee holds a bachelor’s degree from Princeton University and an M.B.A from Harvard Business School.

Rosemarie Loffredo

Rosemarie Loffredo

Chief Administrative Officer and Chief Financial Officer

In her role as chief administrative officer and chief financial officer, Rosemarie Loffredo ensures that LLS achieves the ambitious goals of its long-range strategic plan. Loffredo leads all administrative and staff functions, including finance, information technology and human resources, and she is responsible for enhancing LLS's organizational efficiency and effectiveness in partnership with the organization's executive team.
Earlier in her career, Loffredo served as interim chief financial officer for Pro Mujer International, a nonprofit organization dedicated to empowering disenfranchised women in Latin America through microfinance, healthcare and educational services. She previously served as vice president, financial operations and treasurer of New York University, the largest private research university in the U.S. She also served as senior vice president of finance for CA Technologies, Inc., (formerly Computer Associates), one of the world's largest enterprise management software providers, and prior to that position was vice president of treasury for the International Paper Company. She previously held leadership positions with global banks in international treasury as well as industry segment management including securities and commodities, capital-intensive industry and public finance. Loffredo currently serves on the board of directors of CenterLight Healthcare System.

Loffredo holds a bachelor's degree in international economics, commerce and finance from Georgetown University, a master's degree in economics from Boston College, and an M.B.A in finance and international business from Columbia University.

Alice Rodd O'Rourke

Alice Rodd O'Rourke

Chief Development Officer

Alice Rodd O’Rourke, executive vice president/chief development officer, provides strategic direction and leadership for LLS’s donor development activities, including major gifts from individuals, foundations and corporations. She evaluates the effectiveness of current programs and develops new initiatives to maximize community/corporate/foundation support.

She came to LLS from the American Red Cross, where she served as national vice president of development and helped launch a $500 million annual target. Her previous senior leadership positions include chief marketing officer for Day Pitney LLP, global director development at O’Melveny & Myers LLP, and president of the New York New Media Association, where she helped lead the East Coast’s new media industry to international prominence.

Alice holds a law degree from the Fordham University School of Law and a B.A. in biology and psychology from Manhattanville College